Genmab and Johnson & Johnson Rake in the Bucks Together, Sparking Takeover Speculation Post author:Sam Post published:November 29, 2017 Post category:BioPharma Genmab just received a $20M milestone payment from Janssen Biotech. Source: BioSpace You Might Also Like Troubled Dimension Therapeutics Sold in All-Stock Deal August 24, 2017 With a Collaboration Deal in Place with Merck, Cue Biopharma Plans $60 Million IPO December 18, 2017 A Peek Behind the Curtain of the Ariad-Takeda Deal January 19, 2017
